Wellcare's Expanded 2024 Medicare Advantage and Medicare Prescription Drug Plan Offerings Bring Enhanced Value and Affordability to Members
TAMPA, Fla., Oct. 11, 2023 /PRNewswire/ -- Wellcare, the Medicare brand and wholly owned subsidiary of Centene Corporation (NYSE: CNC), announced today it will expand its wide range of Medicare Advantage (MA) and Medicare Prescription Drug Plan (PDP) offerings during the 2024 Medicare Annual Enrollment Period (AEP), beginning Oct. 15, 2023. This includes the addition of Delaware and expansion into 21 new counties, increasing its total Medicare Advantage footprint to 37 states and 1,808 counties. Wellcare will also now offer the 23 newly designed plans as well as new Dual Eligible Special Needs Plans (D-SNP), accepting all dual eligible beneficiaries, and introduce a Wellcare Spendables™ debit card that will allow pre-loaded funds to be used across 55,000 nationwide retailers in 37 states.
- The investments and innovations we've made like our Wellcare Spendable card will make things simpler and more affordable for our members."
- For 2024, Wellcare will be offering plans to more than 52 million eligible beneficiaries, accounting for 80% of eligible beneficiaries in 37 states.
- More than 1.5 million beneficiaries are currently enrolled in an Wellcare Medicare Advantage plan.
- Express Scripts will be Wellcare's pharmacy benefits manager for 2024, bringing increased value to members to provide quality at the lowest cost.